Fate Therapeutics Gives Up Gains After Early Morning Surge
January 27, 2016 at 10:34 AM EST
Shares of Fate Therapeutics Inc (NASDAQ: FATE), a clinical-stage biopharmaceutical company engaged in the development of programmed ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.